Assignee
BGI SHENZHEN CO LTD
CN·13 granted patents·12 pending applications·7 citations·filing 2012–2022
Top patents by PatentIndex Score
25 records- 0188US11660602B2Temperature control on digital microfluidics deviceBGI SHENZHEN CO LTD·Filed 2020·Granted May 30, 2023·2 cites·20 claims
- 0284US9890375B2Isolated oligonucleotide and use thereof in nucleic acid sequencingBGI SHENZHEN CO LTD·Filed 2014·Granted Feb 13, 2018·3 cites·20 claims
- 0376US9359642B2Method for preparing nucleic acid library, its uses and kitsBGI SHENZHEN CO LTD·Filed 2012·Granted Jun 7, 2016·2 cites·10 claims
- 0470US10023906B2Method for constructing nucleic acid single-stranded cyclic library and reagents thereofBGI SHENZHEN CO LTD·Filed 2014·Granted Jul 17, 2018·0 cites·10 claims
- 0564US2019367995A1Biomarkers for colorectal cancerBGI SHENZHEN CO LTD·Filed 2019·Application pending·0 cites
- 0662US10087216B2Conotoxin polypeptide κ-CPTx-bt101, and method for preparation thereof and application thereofBGI SHENZHEN CO LTD·Filed 2014·Granted Oct 2, 2018·0 cites·10 claims
- 0761US10526659B2Biomarkers for colorectal cancerBGI SHENZHEN CO LTD·Filed 2016·Granted Jan 7, 2020·0 cites·6 claims
- 0858US2024279377A1Preparation of monodisperse polymer beads with room temperature initiation methodsBGI SHENZHEN CO LTD·Filed 2022·Application pending·0 cites
- 0958US2023366023A1Methods and compositions for bioluminescence-based sequencingBGI SHENZHEN CO LTD·Filed 2021·Application pending·0 cites
- 1056US2024271171A1Enzymatic synthesis of oligonucleotidesBGI SHENZHEN CO LTD·Filed 2020·Application pending·0 cites
- 1155US10633416B2Conotoxin polypeptide κ-CPTx-bt104, and method for preparation thereof and application thereofBGI SHENZHEN CO LTD·Filed 2014·Granted Apr 28, 2020·0 cites·9 claims
- 1254US2021069701A1Operation of magnetic beads on microfluidics substratesBGI SHENZHEN CO LTD·Filed 2020·Application pending·0 cites
- 1353US2016153054A1Biomarkers for colorectal cancerBGI SHENZHEN CO LTD·Filed 2016·Application pending·0 cites
- 1451US10344317B2Method and a sequence combination for producing nucleic acid fragmentsBGI SHENZHEN CO LTD·Filed 2014·Granted Jul 9, 2019·0 cites·18 claims
- 1549US10858406B2Conotoxin polypeptide κ-CPTx-bt105, and method for preparation thereof and application thereofBGI SHENZHEN CO LTD·Filed 2014·Granted Dec 8, 2020·0 cites·8 claims
- 1649US10858407B2Conotoxin polypeptide K-CPTX-BT102, and method for preparation thereof and application thereofBGI SHENZHEN CO LTD·Filed 2014·Granted Dec 8, 2020·0 cites·8 claims
- 1749US10662228B2Conotoxin polypeptide κ-CPTx-bt103, and method for preparation thereof and application thereofBGI SHENZHEN CO LTD·Filed 2014·Granted May 26, 2020·0 cites·9 claims
- 1849US2015037286A1Use of roseburia in the prevention and treatment for obesity related diseasesBGI SHENZHEN CO LTD·Filed 2014·Application pending·0 cites
- 1948US2017227528A1Biomarker compositions specific to coronary heart disease patients and uses thereofBGI SHENZHEN CO LTD·Filed 2014·Application pending·0 cites
- 2048US2017234852A1Biomarker compositions specific to coronary heart disease patients and uses thereofBGI SHENZHEN CO LTD·Filed 2014·Application pending·0 cites
- 2147US2018080092A1One-stop treatment method for breaking nucleic acid by means of transposase, and reagentBGI SHENZHEN CO LTD·Filed 2014·Application pending·0 cites
- 2247US2017292153A1Method for breaking nucleic acid and adding adaptor by means of transposase, and reagentBGI SHENZHEN CO LTD·Filed 2014·Application pending·0 cites
- 2344US11822629B2Method and apparatus for generating digital identity and storage mediumBGI SHENZHEN CO LTD·Filed 2020·Granted Nov 21, 2023·0 cites·9 claims
- 2436US2018044668A1Mate pair library constructionBGI SHENZHEN CO LTD·Filed 2015·Application pending·0 cites
- 2532US10954550B2Method and system for screening nanobodyBGI SHENZHEN CO LTD·Filed 2015·Granted Mar 23, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when BGI SHENZHEN CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →